Quantitative real-time PCR was performed to examine the mRNA expression of TET family genes (TET1, TET2, and TET3) in 34 samples, including 6 Grade II gliomas, 7 Grade III gliomas and 21 Grade IV GBM. This evidence concerns the gene TET2 and central nervous system cancer.